Article ID Journal Published Year Pages File Type
10967437 Vaccine 2013 8 Pages PDF
Abstract
In CKD patients, 3 doses of HBsAg-1018 induced significantly higher seroprotection, earlier seroprotection, and more durable seroprotection than 4 double doses of HBsAg-Eng.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Immunology
Preview
Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease
Authors
, , , , , , , , ,